Prospective Comparison of Oral Contrast-Enhanced Transabdominal Ultrasound Imaging With Contrast-Enhanced Computed Tomography in Pre-operative Tumor Staging of Gastric Cancer

Ultrasound Med Biol. 2023 Feb;49(2):569-577. doi: 10.1016/j.ultrasmedbio.2022.10.010. Epub 2022 Nov 9.

Abstract

The aim of this prospective study was to compare the diagnostic accuracy of oral contrast-enhanced transabdominal ultrasound imaging (OCTU) with that of contrast-enhanced computed tomography (CT) for the pre-operative tumor staging of gastric cancer, with post-operative pathology as the standard. We included 108 cases of gastric cancer with simultaneous OCTU and enhanced CT pre-operative tumor staging diagnoses. Results were compared with post-operative pathology based on the eighth edition of the American Joint Committee on Cancer tumor-node-metastasis staging guidelines for gastric cancer. The accuracy of each tumor stage was obtained by comparing OCTU and enhanced CT diagnoses with post-operative pathology. The McNemar test was used to compare the overall accuracy of the two methods. There was no statistical difference in accuracy between OCTU (72.2%) and enhanced CT (75.9%, p = 0.644) for overall pre-operative tumor staging diagnosis. For stages T1 to T4, the accuracy rates of OCTU were 84.2%, 81.8%, 69.4% and 65.5%, respectively, and those for enhanced CT were 52.6%, 72.7%, 87.8% and 72.4%, respectively. OCTU is comparable to enhanced CT in the preoperative overall T-stage diagnosis of gastric cancer.

Keywords: Contrast-enhanced computed tomography; Gastric cancer; Neoplasm staging; Oral contrast-enhanced transabdominal ultrasound imaging.

MeSH terms

  • Humans
  • Neoplasm Staging
  • Prospective Studies
  • Stomach Neoplasms* / diagnostic imaging
  • Stomach Neoplasms* / surgery
  • Tomography, X-Ray Computed / methods
  • Ultrasonography